Source comparison
Kisspeptin-10 vs Kisspeptin-54: Structural and Functional Breakdown
The full-length human kisspeptin peptide exists in multiple isoforms. Kisspeptin-54 (also called metastin), kisspeptin-14, kisspeptin-13, and kisspeptin-10. All derived from the same 145–amino acid prepro-peptide encoded by the KISS1 gene. Post-translational c
This comparison does not assign a generated winner or score.
- The full-length human kisspeptin peptide exists in multiple isoforms. Kisspeptin-54 (also called metastin), kisspeptin-14, kisspeptin-13, and kisspeptin-10. All derived from the same 145–amino acid prepro-peptide encoded by the KISS1 gene. Post-translational cleavage produces these fragments, with all bioactive forms sharing the same conserved C-terminal 10–amino acid sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂. This decapeptide is the minimum structure required to activate GPR54. Truncation beyond this point abolishes receptor binding entirely.
- Kisspeptin-54 was the first isoform identified in human tissue, but enzymatic processing in vivo rapidly degrades it to shorter forms. Plasma half-life for kisspeptin-54 ranges from 27–33 minutes, while kisspeptin-10 persists for 35–42 minutes. A meaningful difference when designing time-course experiments. The extended stability of kisspeptin-10 results from reduced susceptibility to aminopeptidases and carboxypeptidases that cleave at internal peptide bonds present in longer isoforms.
- Functionally, kisspeptin-10 and kisspeptin-54 are indistinguishable at the receptor level. Both activate GPR54 with EC₅₀ values in the low nanomolar range (typically 1–5 nM), both trigger identical intracellular signaling cascades (Gq/11-mediated phospholipase C activation, IP3 production, calcium mobilization), and both produce equivalent LH secretion profiles when administered at equimolar doses. A 2015 comparative study in Journal of Clinical Endocrinology & Metabolism found no statistically significant difference in peak LH response between 1.0 nmol/kg kisspeptin-10 and an equimolar dose of kisspeptin-54 in healthy male volunteers.
- The practical implication: if your research question concerns GPR54 activation, GnRH pulse dynamics, or LH/FSH secretion, kisspeptin-10 delivers identical results with better stability and lower synthesis cost. At Real Peptides, every kisspeptin-10 batch undergoes mass spectrometry verification to confirm the exact 10–amino acid sequence. Position-by-position accuracy matters when receptor binding depends on a single conserved motif.